IL153201A0 - Methods of treating viral diseases with il-18 and il-18 combinations - Google Patents
Methods of treating viral diseases with il-18 and il-18 combinationsInfo
- Publication number
- IL153201A0 IL153201A0 IL15320101A IL15320101A IL153201A0 IL 153201 A0 IL153201 A0 IL 153201A0 IL 15320101 A IL15320101 A IL 15320101A IL 15320101 A IL15320101 A IL 15320101A IL 153201 A0 IL153201 A0 IL 153201A0
- Authority
- IL
- Israel
- Prior art keywords
- combinations
- methods
- viral diseases
- treating viral
- treating
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20886900P | 2000-06-02 | 2000-06-02 | |
PCT/US2001/017924 WO2001093898A1 (en) | 2000-06-02 | 2001-06-01 | Methods of treating viral diseases with il-18 and il-18 combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153201A0 true IL153201A0 (en) | 2003-07-06 |
Family
ID=22776366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15320101A IL153201A0 (en) | 2000-06-02 | 2001-06-01 | Methods of treating viral diseases with il-18 and il-18 combinations |
Country Status (17)
Country | Link |
---|---|
US (1) | US20030113292A1 (xx) |
EP (1) | EP1296707A4 (xx) |
JP (1) | JP2004514652A (xx) |
KR (1) | KR20030007840A (xx) |
CN (1) | CN1457258A (xx) |
AU (2) | AU2001275166B2 (xx) |
BR (1) | BR0111393A (xx) |
CA (1) | CA2411354A1 (xx) |
CZ (1) | CZ20023921A3 (xx) |
HU (1) | HUP0302233A3 (xx) |
IL (1) | IL153201A0 (xx) |
MX (1) | MXPA02011969A (xx) |
NO (1) | NO20025722L (xx) |
NZ (1) | NZ523123A (xx) |
PL (1) | PL363166A1 (xx) |
WO (1) | WO2001093898A1 (xx) |
ZA (1) | ZA200209757B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050013628A (ko) * | 2002-06-27 | 2005-02-04 | 메디비르 아베 | 아바카비르와 알로부딘의 공동상승 상호작용 |
US20050079153A1 (en) * | 2002-08-14 | 2005-04-14 | Pfizer Inc. | Methods for enhancing immune functions in neonatal mammals by administration of IL-18 |
EP1572228A4 (en) * | 2002-09-19 | 2009-03-04 | Centocor Inc | METHOD FOR INDUCING MATURATION OF DENDRITIC CELLS AND USES THEREOF |
AU2004263274B2 (en) | 2003-07-21 | 2009-11-05 | Transgene S.A. | Novel multifunctional cytokines |
DE602004031341D1 (de) * | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
CA2577777A1 (en) * | 2004-08-20 | 2006-03-02 | Smithkline Beecham Corporation | Methods of healing wounds by administering human il-18 |
US20100061958A1 (en) * | 2006-09-14 | 2010-03-11 | The Trustees Of The University Of Pennsylvania | Modulation of Regulatory T Cells by Human IL-18 |
ES2310129B1 (es) | 2007-06-01 | 2009-10-02 | Juan Carlos Garcia Saban | Nueva superficie de implantes metalicos a base de titanio destinados a ser insertado en tejido oseo. |
ES2315194B1 (es) | 2007-09-10 | 2010-02-26 | Francisco J. GARCIA SABAN | Procedimiento para obtener una nueva superficie de un implante metalico a base de titanio destinado a ser insertado en tejido oseo. |
CN104474534A (zh) * | 2014-12-22 | 2015-04-01 | 哈德逊(天津)生物技术有限责任公司 | 白介素-18抗病毒口腔喷剂 |
IL305370A (en) * | 2017-09-06 | 2023-10-01 | Univ Yale | Variants of interleukin-18 and methods of use |
EP4236990A1 (en) | 2020-11-02 | 2023-09-06 | Simcha Il-18, Inc. | Interleukin-18 variants and methods of use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW581771B (en) * | 1994-11-15 | 2004-04-01 | Hayashibara Biochem Lab | Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide |
-
2001
- 2001-06-01 NZ NZ523123A patent/NZ523123A/en unknown
- 2001-06-01 IL IL15320101A patent/IL153201A0/xx unknown
- 2001-06-01 US US10/297,136 patent/US20030113292A1/en not_active Abandoned
- 2001-06-01 HU HU0302233A patent/HUP0302233A3/hu unknown
- 2001-06-01 AU AU2001275166A patent/AU2001275166B2/en not_active Ceased
- 2001-06-01 AU AU7516601A patent/AU7516601A/xx active Pending
- 2001-06-01 CN CN01812880A patent/CN1457258A/zh active Pending
- 2001-06-01 KR KR1020027016425A patent/KR20030007840A/ko not_active Application Discontinuation
- 2001-06-01 BR BR0111393-3A patent/BR0111393A/pt not_active IP Right Cessation
- 2001-06-01 EP EP01941845A patent/EP1296707A4/en not_active Withdrawn
- 2001-06-01 CZ CZ20023921A patent/CZ20023921A3/cs unknown
- 2001-06-01 WO PCT/US2001/017924 patent/WO2001093898A1/en not_active Application Discontinuation
- 2001-06-01 JP JP2002501469A patent/JP2004514652A/ja not_active Withdrawn
- 2001-06-01 PL PL01363166A patent/PL363166A1/xx unknown
- 2001-06-01 MX MXPA02011969A patent/MXPA02011969A/es not_active Application Discontinuation
- 2001-06-01 CA CA002411354A patent/CA2411354A1/en not_active Abandoned
-
2002
- 2002-11-28 NO NO20025722A patent/NO20025722L/no not_active Application Discontinuation
- 2002-12-02 ZA ZA200209757A patent/ZA200209757B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20030113292A1 (en) | 2003-06-19 |
MXPA02011969A (es) | 2004-09-06 |
CA2411354A1 (en) | 2001-12-13 |
CN1457258A (zh) | 2003-11-19 |
NZ523123A (en) | 2005-12-23 |
NO20025722L (no) | 2003-01-24 |
BR0111393A (pt) | 2004-08-24 |
AU2001275166B2 (en) | 2005-07-28 |
PL363166A1 (en) | 2004-11-15 |
HUP0302233A3 (en) | 2006-11-28 |
EP1296707A4 (en) | 2004-03-17 |
EP1296707A1 (en) | 2003-04-02 |
KR20030007840A (ko) | 2003-01-23 |
CZ20023921A3 (cs) | 2003-10-15 |
WO2001093898A1 (en) | 2001-12-13 |
HUP0302233A2 (hu) | 2003-10-28 |
NO20025722D0 (no) | 2002-11-28 |
AU7516601A (en) | 2001-12-17 |
ZA200209757B (en) | 2004-10-04 |
JP2004514652A (ja) | 2004-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0111872D0 (en) | Therapeutic agents and methods | |
IL157577A0 (en) | Disposable underpants and method of providing the same | |
IL162533A0 (en) | Chalcone derivatives and their use to treat diseases | |
EP1360965A4 (en) | METHOD FOR THE TREATMENT OF DISEASES ASSOCIATED WITH A DECREASE OF THE EXPOSURE OF THE AOP-1 GENE OR AOP-1 AND MEANS FOR THE TREATMENT OF THE DISEASES | |
AU6118001A (en) | Combination therapeutic compositions and methods of use | |
IL150468A0 (en) | Improved micro-needles and methods of manufacture and use thereof | |
IL148034A0 (en) | Methods of treating nuclear factor-kappa b mediated diseases and disorders | |
AU2002346504A8 (en) | Therapeutic protein and treatments | |
IL153574A0 (en) | Methods of treating neutrophil-related diseases with topical anesthetics | |
EP1404366A4 (en) | COMBINED THERAPY USING INTERFERON GAMMA AND SPECIFIC B-CELL ANTIBODIES | |
AU8136801A (en) | Methods of preventing or treating diseases and conditions using complex carbohydrates | |
HUP0302233A3 (en) | Methods of treating viral diseases with il-18 and il-18 combinations | |
IL148202A0 (en) | Copolymers and methods of treating prion-related diseases | |
AU9279601A (en) | Compounds and methods for use thereof in the treatment of cancer or viral infections | |
AU2002363938A8 (en) | Methods and use of motoneuronotropic factors | |
EP1263935A4 (en) | SCYTONEMINE AND METHODS OF USE | |
GB0012186D0 (en) | Treatment of cancer and neurological diseases | |
GB0018887D0 (en) | Compound and their therapeutic use | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
HUP0302882A3 (en) | Improved specificity in treatment of diseases | |
GB2381455B (en) | Treatment of burns | |
EP1303281A4 (en) | METHODS OF TREATMENT | |
EP1392460A4 (en) | AMINOSILANOL HYDROFLUORIDES AND THEIR USE | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
AU6884801A (en) | Therapeutic compounds and methods |